HMGA1 and hepatocellular carcinoma: Targeting the NUDT16-HMGA1 pathway exacerbated replication pressure and reduced the stability of stalled replication forks, ultimately improving the sensitivity of hepatocellular carcinoma cells to chemotherapy and IR treatment.